Why the study?
Does polypharmacy increase the risk of short-term ED revisits, hospital readmissions, and mortality in elderly patients treated in emergency departments?
Does polypharmacy increase the risk of short-term ED revisits, hospital readmissions, and mortality in elderly patients treated in emergency departments?
Polypharmacy in elderly emergency department patients is a significant risk factor for short-term ED revisits and hospital readmissions.
Answers are grounded in this paper and cite their sources.
Polypharmacy may flag higher 30-day ED revisit and readmission risk in elderly patients; leaves open causal effects and intervention benefits.
Polypharmacy was common among the elderly treated in EDs and associated with increased risks of ED revisits and hospital readmissions ⩽30 days but not with an increased risk of 30-day mortality. Patients with polypharmacy had a higher risk of ED revisits and hospital readmissions ⩽30 days after discharge.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: